Use of herpes virus amplicon vectors to study brain disorders

BioTechniques

Volumn 39, Issue 3, 2005, Pages 381-389

  Neve, Rachael L ^a   Neve, Kim A ^b   Nestler, Eric J ^c   Carlezon Jr , William A ^a  

^a MCLEAN HOSPITAL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELLS; DISEASES; GENES; HUMAN ENGINEERING; NEUROLOGY; VECTORS; VIRUSES;

BRAIN DISORDERS; HERPES SIMPLEX VIRUS (HSV); IN VITRO AND IN VIVO; NEURONS;

BIOMEDICAL ENGINEERING;

ALZHEIMER DISEASE; AMPLICON; ARTICLE; BRAIN DISEASE; CELL DIVISION; DEPRESSION; GENE EXPRESSION; GENE TARGETING; HERPES SIMPLEX VIRUS 1; HERPESVIRUS VECTOR; IN VITRO STUDY; MEDICAL RESEARCH; NERVE CELL MEMBRANE; VIRUS GENE; ANIMAL; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; METHODOLOGY; REVIEW;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

VIRUS DNA;

ANIMALS; BRAIN DISEASES; DNA, VIRAL; GENE TARGETING; GENETIC VECTORS; HIV-1; HUMANS; TRANSFECTION;

EID: 27744515550     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/05393PS01     Document Type: Article

References (69)

1. Spear, P.G. 1993. Entry of alphaherpes viruses into cells. Semin. Virol. 4:167-180.
2. Honess, R.W. and B. Roizman. 1974. Regulation of herpes virus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:8-19.
3. Fink, D.J., N.A. DeLuca, W.E Goins, and J.C. Glorioso. 1996. Gene transfer to neurons using herpes simplex virus-based vectors. Annu. Rev. Neurosci. 19:265-287.
4. Roizman, B. and F.J. Jenkins. 1985. Genetic engineering of AOR1 genomes of large DNA virus. Science 229:1208-1214.
5. Simonato, M., R. Manservigi, P. Marconi, and J. Glorioso. 2000. Gene transfer into neurons for the molecular analysis of behaviour: focus on herpes simplex vectors. Trends Neurosci. 23:183-190.
6. Mata, M., J.C. Glorioso, and D.J. Fink. 2002. Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiol. Behav. 77:483-488.
7. Goins, W.F., D. Wolfe, D.M. Krisky, Q. Bai, E.A. Burton, D.J. Fink, and J.C. Glorioso. 2004. Delivery using herpes simplex virus: an overview. Methods Mol. Biol. 246:257-299.
8. Spaete, R.R. and N. Frenkel. 1982. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 30:295-304.
9. Spaete, R. and N. Frenkel. 1985. The herpes simplex virus amplicon: analyses of cis-acting replication functions. Proc. Natl. Acad. Sci. USA 82:694-698.
10. Stowe, N. and E. McMonagle. 1982. Propagation of foreign DNA sequences linked to a herpes simplex virus origin of replication, p. 199-204. In Y. Gluzman (Ed.), Eucaryotic Viral Vectors. CSH Laboratory Press, Cold Spring Harbor, NY.
11. Lim, F., D. Hartley, P. Starr, P. Lang, S. Song, L. Yu, Y. Wang, and A.I. Geller. 1996. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques 20:460-470.
12. Lim, F. and R.L. Neve. 1999. Generation of high-titer defective HSV-1 vectors, p. 4.13.1-4.13.17. In Current Protocols in Neuroscience. Greene Publishing Associates and Wiley-Interscience, New York.
13. Carlezon, W.A., Jr. and R.L. Neve. 2002. Viral-mediated gene transfer to study the behavioral correlates of CREB function in the nucleus accumbens of rats, p. 331-350. In J.Q. Wang (Ed.), Drugs of Abuse: Analysis of Neurological Effects, vol. 79 of the series Methods in Molecular Medicine (J.M. Walker, Series Ed.). Humana Press, Totowa, NJ.
14. Fraefel, C., S. Song, F. Lim, P. Lang, L. Yu, Y. Wang, P. Wild, and A.I. Geller. 1996. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70:7190-7197.
15. Sun, M., G.-R. Zhang, T. Yang, L. Yu, and A.I. Geller. 1999. Improved titers for helper virus-free herpes simplex virus type I plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the packaging procedure. Hum. Gene Ther. 10:2005-2011.
16. Bowers, W.J., D.F. Howard, A.I. Brooks, M.W. Halterman, and H.J. Federoff. 2001. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers. Gene Ther. 8:111-120.
17. Wang, X., G.R. Zhang, W. Zhang, and A.I. Geller. 2000. Fifty-one kilobase HSV-1 plasmid vector can be packaged using a helper virus-free system and supports expression in the rat brain. BioTechniques 28:102-107.
18. Saeki, Y., C. Fraefel, T. Ichikawa, X.O. Breakefield, and E.A. Chiocca. 2001. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3:591-601.
19. Tang, J., T. Yang, H.P. Ghosh, and A.I. Geller. 2001. Helper virus-free HSV-1 vectors packaged both in the presence of VSV G protein and in the absence of HSV-1 glycoprotein B support gene transfer into neurons in the rat striatum. J. Neuroviol. 7:548-555.
20. Sun, M., G.-R. Zhang, L. Kong, C. Holmes, X. Wang, W. Zhang, D.S. Goldstein, and A.I. Geller. 2003. Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type I vector. Hum. Gene Ther. 14:415-424.
21. Ferrera, R., D. Cuchet, C. Zaupa, V. Revol-Guyot, M. Ovize, and A.L. Epstein. 2005. Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1. J. Mol. Cell. Cardiol. 38:219-223.
22. Carlezon, W.A., Jr., V.A. Boundy, C.N. Haile, S.B. Lane, R.G. Kalb, R.L. Neve, and E.J. Nestler. 1997. Sensitization to morphine induced by viral-mediated gene transfer. Science 277:812-814.
23. Carlezon, W.A., Jr., J. Thome, V. Olson, S.B. Lane-Ladd, E.S. Brodkin, N. Hiroi, R.S. Duman, R.L. Neve, and E.J. Nestler. 1998. Regulation of cocaine reward by CREB. Science 282:2272-2275.
24. Kelz, M.B., J.S. Chen, W.A. Carlezon, Jr., K. Whisler, L. Gilden, A.M. Beckmann, C. Steffen, Y.J. Zhang, et al. 1999. Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine. Nature 401:272-276.
25. Jin, B.K., M. Belloni, B. Conti, H.J. Federoff, R. Starr, J.H. Son, H. Baker, and T.H. Joh. 1996. Prolonged in vivo gene expression by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Hum. Gene Ther. 7:2015-2024.
26. Wang, S. and J. Vos. 1996. A hybrid herpes-virus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol. 70:8422-8430.
27. Johnston, K.M., D. Jacoby, P. Pechan, C. Fraefel, P. Borghesani, D. Schuback, R.J. Dunn, F.I. Smith, and X.O. Breakefield. 1997. HSC/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8:359-370.
28. Fraefel, C., D.R. Jacoby, C. Lage, H. Hilderbrand, J.Y. Chou, F.W. Alt, X.O. Breakefield, and J.A. Majzoub. 1997. Gene transfer into hepatocytes mediated by helper virus free HSV/AAV hybrid vectors. Mol. Med. 3:813-825.
29. Constantini, L.C., D.R. Jacoby, S. Wang, C. Fraefel, X.O. Breakefield, and O. Isacson. 1999. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Hum. Gene Ther. 10:2441-2494.
30. Zhang, G., X. Wang, T. Yang, M. Sun, W. Zhang, Y. Wang, and A.I. Geller. 2000. A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors. Brain Res. Mol. Brain Res. 84:17-31.
31. Wang, X., L. Kong, G.R. Zhang, M. Sun, and A.I. Geller. 2004. A preproenkephalin-neurofilament chimeric promoter in a helper virus-free herpes simplex virus vector enhances long-term expression in the rat striatum. Neurobiol. Dis. 16:596-603.
32. Coopersmith, R. and R.L. Neve. 1999. Expression of multiple proteins within single primary cortical neurons using a replication deficient HSV vector. BioTechniques 27:1156-1159.
33. Krisky, D.M., P.C. Marconi, T.J. Oligino, R.J. Rouse, D.J. Fink, J.B. Cohen, S.C. Watkins, and J.C. Glorioso. 1998. Development of herpes simplex replication-defective multigene vectors for combination gene therapy applications. Gene Ther. 5:1517-1530.
34. Wagstaff, M.J., C.E. Lilley, J. Smith, M.J. Robinson, R.S. Coffin, and D.S. Latchman. 1998. Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo. Gene Ther. 5:1566-1570.
35. Bursztajn, S., R. DeSouza, D.L. McPhie, S.A. Berman, J. Shioi, N.K. Robakis, and R.L. Neve. 1998. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J. Neurosci. 18:9790-9799.
36. Bahr, B.A., R.L. Neve, J. Sharp, A.I. Geller, and G. Lynch. 1994. Rapid and stable gene expression in hippocampal slice cultures from a defective HSV-1 vector. Brain Res. Mol. Brain Res. 26:277-285.
37. Clark, M.S., T.J. Sexton, M. McClain, D. Root, R. Kohen, and J.E Neumaier. 2002. Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress. J. Neurosci. 22:4550-4562.
38. Herrup, K., R. Neve, S. Ackerman, and A. Copani. 2004. Divide and die: cell cycle events as triggers of nerve cell death. J. Neurosci. 24:9232-9239.
39. McPhie, D.L., T. Golde, C.B. Eckman, D. Yager, S.G. Younkin, and R.L. Neve. 2001. The β-secretase cleavage product of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Brain Res. Mol. Brain Res. 97:103-113.
40. McPhie, D.L., R. Coopersmith, A. Hines-Peralta, Y. Chen, K.J. Ivins, S.P. Manly, M.R. Kozlowski, K.A. Neve, and R.L. Neve. 2003. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J. Neurosci. 23:6914-6927.
41. Manser, E., C. Chong, Z.S. Zhao, T. Leung, G. Michael, C. Hall, and L. Lim. 1995. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J. Biol. Chem. 270:25070-25078.
42. Chow, N., J.R. Korenberg, X.-N. Chen, and R.L. Neve. 1996. APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J. Biol. Chem. 271:11339-11346.
43. Chen, Y., D.L. McPhie, J. Hirschberg, and R.L. Neve. 2000. The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J. Biol. Chem. 275:8929-8935.
44. Chen, Y., W. Liu, D.L. McPhie, L. Hassinger, and R.L. Neve. 2003. APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. J. Cell Biol. 163:27-33.
45. αo by D2L dopamine receptors in NS20Y neuroblastoma cells. J. Neurosci. 18:8692-8699.
46. αs-insensitive mutants of adenylyl cyclase V. Mol. Pharmacol. 60:1168-1172.
47. αs alters vasoreactivity. Clin. Exp. Pharmacol. Physiol. 27:9-13.
48. During, M.J., J.R. Naegele, K.L. O'Malley, and A.I. Geller. 1994. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403.
49. Isacson, O. 1995. Behavioral effects and gene delivery in a rat model of Parkinson's disease. Science 269:856-857.
50. Nestler, E.J. 2001. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2:119-128.
51. Lett, B.T. 1989. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berlin) 98:357-362.
52. Piazza, P.V., J.M. Deminiere, M. le Moal, and H. Simon. 1990. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:22-26.
53. Carlezon, W.A., Jr. and E.J. Nestler. 2002. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci. 25:610-615.
54. Robinson, T.E. and K.C. Berridge. 2001. Incentive-sensitization and addiction. Addiction 96:103-114.
55. Fitzgerald, L.W., J. Ortiz, A.G. Hamedani, and E.J. Nestler. 1996. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16:274-282.
56. Churchill, L., C.J. Swanson, M. Urbine, and P.W. Kalivas. 1999. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J. Neurochem. 72:2397-2403.
57. Carlezon, W.A., Jr., C.N. Haile, R. Coopersmith, Y. Hayashi, R. Malinow, R.L. Neve, and E.J. Nestler. 2000. Distinct sites of opiate reward and aversion within the mid-brain identified by a herpes simplex virus vector expressing GluR1. J. Neurosci. 20:RC62, 1-5.
58. Cole, R.L., C. Konradi, J. Douglass, and S.E. Hyman. 1995. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14:813-823.
59. Turgeon, S.M., A.E. Pollack, and J.S. Fink. 1997. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res. 749:120-126.
60. Shaywitz, A.J. and M.E. Greenberg. 1999. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:821-861.
61. Hurd, Y.L., E.E. Brown, J.M. Finlay, H.C. Fibiger, and C.R. Gerfen. 1992. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res. Mol. Brain Res. 13:165-170.
62. Pfeiffer, A., V. Brantl, A. Herz, and H.M. Emrich. 1986. Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776.
63. Pliakas, A.M., R. Carlson, R.L. Neve, C. Konradi, E.J. Nestler, and W.A. Carlezon, Jr. 2001. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element binding protein expression in nucleus accumbens. J. Neurosci. 21:7397-7403.
64. Barrot, M., J.D. Olivier, L.I. Perrotti, R.J. DiLeone, O. Berton, A.J. Eisch, S. Impey, D.R. Storm, et al. 2002. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. USA 99:11435-11440.
65. Newton, S.S., J. Thome, T.L. Wallace, Y. Shirayama, L. Schlesinger, N. Sakai, J. Chen, R. Neve, et al. 2002. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22:10883-10890.
66. Mague, S.D., A.M. Pliakas, M.S. Todtenkope, H.C. Tomasiewicz, Y. Zhang, W.C. Stevene, Jr., R.M. Jones, P.S. Portoghese, and W.A. Carlezon, Jr. 2003. Antidepressant-like effects of kappa opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 305:323-330.
67. Todtenkopf, M.S., J.E Marcus, P.S. Portoghese, and W.A. Carlezon, Jr. 2004. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berlin) 172:463-470.
68. Glorioso, J.C. and D.J. Fink. 2004. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu. Rev. Microbiol. 58:253-271.
69. Yenari, M.A. and R.M. Sapolsky. 2005. Gene therapy in neurological disease. Methods Mol. Med. 104:75-88.